Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemangiosarcoma × pazopanib × Clear all

Phase

Phase 2 3 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 8 Sarcoma 4 Neoplasms 2 Neoplasm Metastasis 2 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1

Interventions

Ifosfamide 5 Doxorubicin 5 Radiotherapy 3 Filgrastim 2 pegfilgrastim 1 pazopanib 1 indolepropanol phosphate 1 carotuximab 1 Watchful Waiting 1 Radiotherapy, Conformal 1 Observation 1 Cyproheptadine 1 Combined Modality Therapy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed

128 enrolled 13 charts

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡